1
|
Turrentine M, Nguyen BH, Choby B, Kendig S, King TL, Kotelchuck M, Moore Simas TA, Srinivas SK, Zahn CM, Peahl AF. Frequency of Prenatal Care Visits: A Core Outcome Set for Prenatal Care Schedules. J Womens Health (Larchmt) 2024; 33:715-722. [PMID: 38306165 DOI: 10.1089/jwh.2023.0592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2024] Open
Abstract
Objective: The aim of this study is to develop a core outcome set for the frequency and modality of prenatal care visits. Material and Methods: A consensus development study was conducted in the United States with participants, including 31 health care professionals, 12 public policy members or public health payers, and 18 public members, representing 24 states. A modified Delphi method and modified nominal group technique were utilized. Results: Twenty-one potential core outcomes were developed by combining the outcomes reported in three systematic reviews that evaluated the frequency of prenatal care visits or modality of prenatal visit type (e.g., in person, telemedicine, or hybrids of both). Eighteen consensus outcomes were identified from the Delphi process, following which 10 maternal and 4 neonatal outcomes were agreed at the consensus development meeting. Maternal core outcomes include maternal quality of life; maternal mental health outcomes; the experience of maternity care; lost time; attendance of recommended visits; unplanned care utilization; completion of the American College of Obstetricians and Gynecologists-recommended services; diagnosis of obstetric complications-proportion and timing; disparities in care outcomes; and severe maternal morbidity or mortality. Neonatal core outcomes include gestational age at birth, birth weight, stillbirth or perinatal death, and neonatal intensive care unit admissions. Conclusions: The core outcome set for the frequency and modality of prenatal visits should be utilized in forthcoming randomized controlled trials and systematic reviews. Such application will warrant that in future research, consistent reporting will enrich care and improve outcomes. Clinical Trial Registration number: 2021.
Collapse
Affiliation(s)
- Mark Turrentine
- Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA
| | - Buu-Hac Nguyen
- University of Michigan College of Literature, Science, and the Arts, Ann Arbor, Michigan, USA
| | - Beth Choby
- Baptist University College of Osteopathic Medicine, Baptist Health Sciences University, Memphis, Tennessee, USA
| | - Susan Kendig
- Maternal Services, SSM Health St. Louis Region, Shiloh, Illinois, USA
| | - Tekoa L King
- Department of Family Health Care Nursing, San Francisco School of Nursing, University of California, San Francisco, California, USA
| | - Milton Kotelchuck
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA
| | - Tiffany A Moore Simas
- Department of Obstetrics and Gynecology, Pediatrics, Psychiatry, and Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA
| | - Sindhu K Srinivas
- Department of Obstetrics and Gynecology, Penn Medicine, Philadelphia, Pennsylvania, USA
| | - Christopher M Zahn
- Clinical Practice and Health Equity and Quality, American College of Obstetricians and Gynecologists, Washington, District of Columbia, USA
| | - Alex Friedman Peahl
- Department of Obstetrics and Gynecology, Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA
| |
Collapse
|